From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
出版年份 2019 全文链接
标题
From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-06
DOI
10.1007/s13311-019-00798-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Extra-Cerebellar Signs and Non-motor Features in Chinese Patients With Spinocerebellar Ataxia Type 3
- (2019) Xiaoqin Yuan et al. Frontiers in Neurology
- Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms
- (2019) Shala G. Berntsson et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Guidelines on the diagnosis and management of the progressive ataxias
- (2019) Rajith de Silva et al. Orphanet Journal of Rare Diseases
- The proteostasis network and its decline in ageing
- (2019) Mark S. Hipp et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- RNAi therapy for Machado-Joseph disease: long-term safety profile of lentiviral vectors encoding shRNAs targeting mutant ataxin-3
- (2019) Clévio Nobrega et al. HUMAN GENE THERAPY
- Spinocerebellar ataxia
- (2019) Thomas Klockgether et al. Nature Reviews Disease Primers
- Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia
- (2019) Clévio Nóbrega et al. ACTA NEUROPATHOLOGICA
- Altered Levels of Proteins and Phosphoproteins, in the Absence of Early Causative Transcriptional Changes, Shape the Molecular Pathogenesis in the Brain of Young Presymptomatic Ki91 SCA3/MJD Mouse
- (2019) Kalina Wiatr et al. MOLECULAR NEUROBIOLOGY
- Oligonucleotide therapy mitigates disease in Spinocerebellar Ataxia Type 3 mice
- (2018) Hayley S. McLoughlin et al. ANNALS OF NEUROLOGY
- Structural signature of SCA3: from presymptomatic to late disease stages
- (2018) Thiago Junqueira Ribeiro Rezende et al. ANNALS OF NEUROLOGY
- Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3
- (2018) Zi-Jian Wang et al. CNS Neuroscience & Therapeutics
- Management of hypertonia in cerebral palsy
- (2018) Nickolas J. Nahm et al. CURRENT OPINION IN PEDIATRICS
- Machado-Joseph disease / Spinocerebellar ataxia type 3:lessons from disease pathogenesis and clues into therapy
- (2018) Carlos Matos et al. JOURNAL OF NEUROCHEMISTRY
- Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
- (2018) Lodewijk J. A. Toonen et al. Molecular Neurodegeneration
- Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3
- (2018) Sara Duarte-Silva et al. MOVEMENT DISORDERS
- Mass spectrometry analyses of normal and polyglutamine expanded ataxin-3 reveal novel interaction partners involved in mitochondrial function
- (2018) Line V. Kristensen et al. NEUROCHEMISTRY INTERNATIONAL
- CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells
- (2018) Shuming Ouyang et al. STEM CELLS AND DEVELOPMENT
- A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3
- (2018) Ray-Yau Wang et al. Scientific Reports
- Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease models
- (2018) Adriana Marcelo et al. HUMAN MOLECULAR GENETICS
- Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease
- (2018) Sofia Esteves et al. MOLECULAR NEUROBIOLOGY
- Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease
- (2018) Naila S. Ashraf et al. MOLECULAR NEUROBIOLOGY
- Upregulation of miR-370 and miR-543 is associated with reduced expression of heat shock protein 40 in spinocerebellar ataxia type 3
- (2018) Bernd O. Evert et al. PLoS One
- Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways
- (2018) Li Zeng et al. PLoS One
- Choosing not to know: accounts of non-engagement with pre-symptomatic testing for Machado-Joseph disease
- (2018) Álvaro Mendes et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Distinct proteostasis circuits cooperate in nuclear and cytoplasmic protein quality control
- (2018) Rahul S. Samant et al. NATURE
- Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3
- (2018) Tina Harmuth et al. Frontiers in Molecular Neuroscience
- Nusinersen for the treatment of spinal muscular atrophy
- (2017) Claudia A. Chiriboga Expert Review of Neurotherapeutics
- Construct Validity and Reliability of the SARA Gait and Posture Sub-scale in Early Onset Ataxia
- (2017) Tjitske F. Lawerman et al. Frontiers in Human Neuroscience
- Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
- (2017) Joanna R. Sutton et al. HUMAN MOLECULAR GENETICS
- Pathways of cellular proteostasis in aging and disease
- (2017) Courtney L. Klaips et al. JOURNAL OF CELL BIOLOGY
- Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease
- (2017) Vitor Carmona et al. MOLECULAR THERAPY
- Polyglutamine tracts regulate beclin 1-dependent autophagy
- (2017) Avraham Ashkenazi et al. NATURE
- Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients
- (2017) Annie Sittler et al. NEUROPATHOLOGY
- n -Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3
- (2017) Karthyayani Rajamani et al. NEUROPHARMACOLOGY
- Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov
- (2017) Siew Wan Hee et al. Orphanet Journal of Rare Diseases
- Nusinersen for the treatment of spinal muscular atrophy
- (2017) Claudia A. Chiriboga Expert Review of Neurotherapeutics
- Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
- (2017) Lauren R. Moore et al. Molecular Therapy-Nucleic Acids
- Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia
- (2017) Yeliz Salcı et al. Multiple Sclerosis and Related Disorders
- Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3
- (2016) Maria do Carmo Costa et al. BRAIN
- PNKP Mutations Identified by Whole-Exome Sequencing in a Norwegian Patient with Sporadic Ataxia and Edema
- (2016) C. Tzoulis et al. CEREBELLUM
- History of Orphan Drug Regulation-United States and Beyond
- (2016) ME Haffner CLINICAL PHARMACOLOGY & THERAPEUTICS
- Protein quality control in the nucleus
- (2016) Ramon D Jones et al. CURRENT OPINION IN CELL BIOLOGY
- Reliability and discriminant validity of ataxia rating scales in early onset ataxia
- (2016) Rick Brandsma et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Outcome of Rehabilitation and Swallowing Therapy after Percutaneous Endoscopic Gastrostomy in Dysphagia Patients
- (2016) Ezekiel Wong Toh Yoon et al. DYSPHAGIA
- Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models
- (2016) Carlos A. Matos et al. JOURNAL OF CELL BIOLOGY
- In vivoassessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3
- (2016) Jana Schmidt et al. JOURNAL OF NEUROCHEMISTRY
- Chronic ingestion of a low dose of caffeine induces tolerance to the performance benefits of caffeine
- (2016) Ross Beaumont et al. JOURNAL OF SPORTS SCIENCES
- Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper
- (2016) Susana Otero-Romero et al. Multiple Sclerosis Journal
- Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
- (2016) David M. Simpson et al. NEUROLOGY
- Safety and efficacy of valproic acid treatment in SCA3/MJD patients
- (2016) Li-Fang Lei et al. PARKINSONISM & RELATED DISORDERS
- Botulinum Toxin Treatment of Spasticity in Adults and Children
- (2016) Iman Moeini-Naghani et al. SEMINARS IN NEUROLOGY
- Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathway
- (2016) Janete Cunha-Santos et al. Nature Communications
- The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53
- (2016) Hongmei Liu et al. PLOS BIOLOGY
- Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper
- (2016) Susana Otero-Romero et al. Multiple Sclerosis Journal
- Mutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4
- (2015) Jose Bras et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease
- (2015) Andreia Teixeira-Castro et al. BRAIN
- Neurogenic muscle cramps
- (2015) Hans D. Katzberg JOURNAL OF NEUROLOGY
- Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial
- (2015) Jonas Alex Morales Saute et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
- (2015) Silvia Romano et al. LANCET NEUROLOGY
- Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study
- (2015) Heike Jacobi et al. LANCET NEUROLOGY
- Neuropathic Pain: Principles of Diagnosis and Treatment
- (2015) Ian Gilron et al. MAYO CLINIC PROCEEDINGS
- The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster
- (2015) Wei-Ling Tsou et al. NEUROBIOLOGY OF DISEASE
- T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse
- (2015) An-Hsun Chou et al. NEUROPHARMACOLOGY
- A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders
- (2015) Ryuji Sakakibara et al. NEUROUROLOGY AND URODYNAMICS
- Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review
- (2015) J Lui et al. SPINAL CORD
- Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group
- (2015) Trevor Richter et al. VALUE IN HEALTH
- Ataxin-3, DNA Damage Repair, and SCA3 Cerebellar Degeneration: On the Path to Parsimony?
- (2015) Jacqueline M. Ward et al. PLoS Genetics
- Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3
- (2015) Rui Gao et al. PLoS Genetics
- The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis
- (2015) Arpita Chatterjee et al. PLoS Genetics
- Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease
- (2015) Sofia Esteves et al. PLoS One
- Spinocerebellar ataxia type 3: subphenotypes in a cohort of brazilian patients
- (2014) Adriana Moro et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation
- (2014) An-Hsun Chou et al. BRAIN RESEARCH
- Lithium Chloride Therapy Fails to Improve Motor Function in a Transgenic Mouse Model of Machado-Joseph Disease
- (2014) Sara Duarte-Silva et al. CEREBELLUM
- How the Nucleus Copes with Proteotoxic Stress
- (2014) Yoko Shibata et al. CURRENT BIOLOGY
- EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood
- (2014) B. P. C. van de Warrenburg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells
- (2014) Andreia Neves-Carvalho et al. HUMAN MOLECULAR GENETICS
- Valproic acid attenuates the suppression of acetyl histone H3 and CREB activity in an inducible cell model of Machado–Joseph disease
- (2014) X.P. Lin et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- A Systematic Review of Approaches for Engaging Patients for Research on Rare Diseases
- (2014) Laura P. Forsythe et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Differential mtDNA Damage Patterns in a Transgenic Mouse Model of Machado–Joseph Disease (MJD/SCA3)
- (2014) Amanda Ramos et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration
- (2014) Jan Liman et al. JOURNAL OF NEUROCHEMISTRY
- A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease
- (2014) Jonas Alex Morales Saute et al. MOVEMENT DISORDERS
- The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies
- (2014) Luis Ruano et al. NEUROEPIDEMIOLOGY
- Chronic Treatment with 17-DMAG Improves Balance and Coordination in A New Mouse Model of Machado-Joseph Disease
- (2014) Anabela Silva-Fernandes et al. Neurotherapeutics
- Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition
- (2014) A. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteostasis impairment in protein-misfolding and -aggregation diseases
- (2014) Mark S. Hipp et al. TRENDS IN CELL BIOLOGY
- Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23
- (2014) Jessica R. Blount et al. Nature Communications
- Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: Implication in a loss-of-function pathology
- (2014) Hui Yang et al. Scientific Reports
- Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado–Joseph disease
- (2013) Isabel Nascimento-Ferreira et al. BRAIN
- Mutant Ataxin-3 with an Abnormally Expanded Polyglutamine Chain Disrupts Dendritic Development and Metabotropic Glutamate Receptor Signaling in Mouse Cerebellar Purkinje Cells
- (2013) Ayumu Konno et al. CEREBELLUM
- The effectiveness of allied health care in patients with ataxia: a systematic review
- (2013) Ella M. R. Fonteyn et al. JOURNAL OF NEUROLOGY
- H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse
- (2013) Hung-Li Wang et al. NEUROPHARMACOLOGY
- SUMO-1 Modification on K166 of PolyQ-Expanded aTaxin-3 Strengthens Its Stability and Increases Its Cytotoxicity
- (2013) Ya-Fang Zhou et al. PLoS One
- Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4
- (2013) Jiping Yi et al. PLoS One
- Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
- (2013) Udo Rüb et al. PROGRESS IN NEUROBIOLOGY
- Challenges and opportunities of drug repositioning
- (2013) Natalia Novac TRENDS IN PHARMACOLOGICAL SCIENCES
- Side-effects associated with targeted therapies in renal cell carcinoma
- (2013) Denis Soulières Current Opinion in Supportive and Palliative Care
- Brain pathology of spinocerebellar ataxias
- (2012) Kay Seidel et al. ACTA NEUROPATHOLOGICA
- Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease
- (2012) A. T. Simoes et al. BRAIN
- Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)
- (2012) J. Hubener et al. HUMAN MOLECULAR GENETICS
- Ataxin-3 Regulates Aggresome Formation of Copper-Zinc Superoxide Dismutase (SOD1) by Editing K63-linked Polyubiquitin Chains
- (2012) Hongfeng Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Automated Behavioral Phenotyping Reveals Presymptomatic Alterations in a SCA3 Genetrap Mouse Model
- (2012) Jeannette Hübener et al. Journal of Genetics and Genomics
- Patterns of Mitochondrial DNA Damage in Blood and Brain Tissues of a Transgenic Mouse Model of Machado-Joseph Disease
- (2012) Nadiya Kazachkova et al. Neurodegenerative Diseases
- A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3
- (2012) T. A. Zesiewicz et al. NEUROLOGY
- A protective effect of 5-HT3 antagonist against vestibular deficit? Metoclopramide versus ondansetron at the early stage of vestibular neuritis: A pilot study
- (2012) F. Venail et al. European Annals of Otorhinolaryngology-Head and Neck Diseases
- Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease
- (2011) Isabel Nascimento-Ferreira et al. BRAIN
- N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation
- (2011) Jeannette Hübener et al. BRAIN
- Calcium and cell death mechanisms: A perspective from the cell death community
- (2011) Boris Zhivotovsky et al. CELL CALCIUM
- Pathoanatomy of Cerebellar Degeneration in Spinocerebellar Ataxia Type 2 (SCA2) and Type 3 (SCA3)
- (2011) W. Scherzed et al. CEREBELLUM
- FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3
- (2011) Julieta Araujo et al. HUMAN MOLECULAR GENETICS
- Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease
- (2011) Philipp Koch et al. NATURE
- European regulation on orphan medicinal products: 10 years of experience and future perspectives
- (2011) NATURE REVIEWS DRUG DISCOVERY
- The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: A 2-year follow-up study
- (2011) H. Jacobi et al. NEUROLOGY
- Machado-Joseph Disease: from first descriptions to new perspectives
- (2011) Conceição Bettencourt et al. Orphanet Journal of Rare Diseases
- Elevated cerebrospinal fluid lactate/pyruvate ratio in Machado-Joseph disease
- (2010) T. Matsuishi et al. ACTA NEUROLOGICA SCANDINAVICA
- Axonal inclusions in spinocerebellar ataxia type 3
- (2010) Kay Seidel et al. ACTA NEUROPATHOLOGICA
- Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA)
- (2010) Pedro Braga-Neto et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Occupational therapy in spinocerebellar ataxia type 3: an open-label trial
- (2010) R.C.R. Silva et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Difference in the Effects of Tandospirone on Ataxia in Various Types of Spinocerebellar Degeneration: An Open-Label Study
- (2010) Asako Takei et al. CEREBELLUM
- Neuropsychological Features of Patients with Spinocerebellar Ataxia (SCA) Types 1, 2, 3, and 6
- (2010) Ina Klinke et al. CEREBELLUM
- Resveratrol: Challenges in Translation to the Clinic -- A Critical Discussion
- (2010) L. Subramanian et al. CLINICAL CANCER RESEARCH
- Silencing ataxin-3 mitigates degeneration in a rat model of Machado–Joseph disease: no role for wild-type ataxin-3?
- (2010) Sandro Alves et al. HUMAN MOLECULAR GENETICS
- The Machado–Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability
- (2010) Thomas M. Durcan et al. HUMAN MOLECULAR GENETICS
- Activity and Cellular Functions of the Deubiquitinating Enzyme and Polyglutamine Disease Protein Ataxin-3 Are Regulated by Ubiquitination at Lysine 117
- (2010) Sokol V. Todi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear Aggregation of Polyglutamine-expanded Ataxin-3
- (2010) Peter Breuer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor
- (2010) Patric Blomstedt et al. MOVEMENT DISORDERS
- HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
- (2010) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons
- (2010) An-Hsun Chou et al. NEUROCHEMISTRY INTERNATIONAL
- Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial
- (2010) G. Ristori et al. NEUROLOGY
- Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
- (2010) M. R. Delgado et al. NEUROLOGY
- Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels
- (2010) Maria do Carmo Costa et al. PLoS One
- Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?
- (2010) T. Takahashi et al. Journal of Molecular Cell Biology
- Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
- (2009) Fiona M. Menzies et al. BRAIN
- New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease)
- (2009) Udo Rüb et al. CURRENT OPINION IN NEUROLOGY
- Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3
- (2009) Sokol V Todi et al. EMBO JOURNAL
- What, if anything, is specific about having a rare disorder? Patients’ judgements on being ill and being rare
- (2009) Caroline Huyard HEALTH EXPECTATIONS
- Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
- (2009) Joonil Jung et al. HUMAN MOLECULAR GENETICS
- CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3
- (2009) Thorsten Mueller et al. HUMAN MOLECULAR GENETICS
- Axonal Dysfunction in the Deep White Matter in Machado-Joseph Disease
- (2009) Anelyssa D'Abreu et al. JOURNAL OF NEUROIMAGING
- Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease
- (2009) Ya-Chun Yu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Evidence-Based Recommendations for the Assessment and Management of Sleep Disorders in Older Persons
- (2009) Harrison G. Bloom et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Intensive coordinative training improves motor performance in degenerative cerebellar disease
- (2009) W. Ilg et al. NEUROLOGY
- Caring for Machado–Joseph disease: Current understanding and how to help patients
- (2009) Anelyssa D'Abreu et al. PARKINSONISM & RELATED DISORDERS
- SCA3: Neurological features, pathogenesis and animal models
- (2008) Olaf Riess et al. CEREBELLUM
- Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease
- (2008) Sandro Alves et al. HUMAN MOLECULAR GENETICS
- Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3
- (2008) X. Chen et al. JOURNAL OF NEUROSCIENCE
- Empowerment of patients: lessons from the rare diseases community
- (2008) Ségolène Aymé et al. LANCET
- Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
- (2008) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- Study of subcellular localization and proteolysis of ataxin-3
- (2008) Chiara Pozzi et al. NEUROBIOLOGY OF DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started